News

Melbourne (Australia) and Nantes (France) – 11 September 2018. Telix Pharmaceuticals Limited today announced the...
Read More →
Melbourne (Australia) and Nantes (France) – 11 September 2018. Telix Pharmaceuticals Limited today announced the...
Read More →
Melbourne (Australia), Brussels (Belgium) – 4th September 2018. Telix Pharmaceuticals Limited has received ethics approval...
Read More →
Melbourne, Australia, Aug. 31 2018 – Telix Pharmaceuticals Limited is pleased to provide its Half-Year Report 2018,...
Read More →
MELBOURNE, Australia, and MONTREAL, Canada – 25 June 2018. Telix Pharmaceuticals has announced a technology...
Read More →
Goetzpartners securities Limited (“Goetzpartners”), a leading pan-European investment bank and research firm, has initiated research...
Read More →
Telix Pharmaceuticals Ltd and ANMI SA will be running a joint user meeting for the...
Read More →
MELBOURNE, Australia – 18 June 2018. Telix Pharmaceuticals today announced that a consortium of industry collaborators,...
Read More →
Telix has selected Goodwin Biotechnology, Inc. to optimize the process for cGMP manufacturing of our renal...
Read More →
The 29:81 (April 2018) edition edition of BioWorld has a very nice little write up on Telix...
Read More →